Clinical Trial Update: Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH) [Phase 2]

View source ↗

Summary

Phase 2 trial update examining the effect of JKB-122 on remission in autoimmune hepatitis induced by prednisolone and azathioprine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hepatitis

Drugs mentioned

• JKB-122

Snippet

Sponsor: TaiwanJ Pharmaceuticals Co., Ltd | Conditions: Autoimmune Hepatitis | Phase 2 | Status: UNKNOWN